相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic Cardiomyopathy
Iacopo Olivotto et al.
MAYO CLINIC PROCEEDINGS (2012)
The Cardiac Myosin Binding Protein C Arg502Trp Mutation A Common Cause of Hypertrophic Cardiomyopathy
Adam J. Saltzman et al.
CIRCULATION RESEARCH (2010)
Genetics of hypertrophic cardiomyopathy
Tetsuo Konno et al.
CURRENT OPINION IN CARDIOLOGY (2010)
The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening
Imke Christiaans et al.
EUROPEAN HEART JOURNAL (2010)
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β
Polakit Teekakirikul et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations
Francesca Girolami et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
Carolyn Y. Ho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Echocardiographic Strain Imaging to Assess Early and Late Consequences of Sarcomere Mutations in Hypertrophic Cardiomyopathy
Carolyn Y. Ho et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
Clinical Outcome and Phenotypic Expression in LAMP2 Cardiomyopathy
Barry J. Maron et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Genomic copy number variation, human health, and disease
Louise V. Wain et al.
LANCET (2009)
Filter-based hybridization capture of subgenomes enables resequencing and copy-number detection
Daniel S. Herman et al.
NATURE METHODS (2009)
Shared genetic causes of cardiac hypertrophy in children and adults
Hiroyuki Morita et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy
Jae Bum Kim et al.
SCIENCE (2007)
Reviews of translational medicine and genomics in cardiovascular disease: New disease taxonomy and therapeutic implications - Cardiomyopathies: Therapeutics based on molecular phenotype
Houman Ashrafian et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Agalsidase-beta therapy for advanced Fabry disease - A randomized trial
Maryam Banikazemi et al.
ANNALS OF INTERNAL MEDICINE (2007)
Single-gene mutations and increased left ventricular wall thickness in the community - The Framingham Heart Study
Hiroyuki Morita et al.
CIRCULATION (2006)
Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin
JM Bos et al.
MOLECULAR GENETICS AND METABOLISM (2006)
Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation
AJ Marian et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling
J Ingles et al.
JOURNAL OF MEDICAL GENETICS (2005)
Sarcomeric proteins and familial hypertrophic cardiomyopathy: Linking mutations in structural proteins to complex cardiovascular phenotypes
JC Tardiff
HEART FAILURE REVIEWS (2005)
Glycogen storage diseases presenting as hypertrophic cardiomyopathy
M Arad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy
N Tsybouleva et al.
CIRCULATION (2004)
Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy
BJ Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy
SL Van Driest et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Mutations of the β myosin heavy chain gene in hypertrophic cardiomyopathy:: critical functional sites determine prognosis
A Woo et al.
HEART (2003)
Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease
SF Nagueh et al.
CIRCULATION (2003)
Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy
JG Crilley et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Hypertrophic cardiomyopathy - Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy
P Richard et al.
CIRCULATION (2003)
Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy
C Geier et al.
CIRCULATION (2003)
Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy
L Choudhury et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Prevalence and severity of Benign mutations in the β-myosin heavy chain, cardiac troponin T, and α-tropomyosin genes in hypertrophic cardiomyopathy
SL Van Driest et al.
CIRCULATION (2002)
Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy
CY Ho et al.
CIRCULATION (2002)
Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy - A comprehensive outpatient perspective
MJ Ackerman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model
C Semsarian et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy
B Sachdev et al.
CIRCULATION (2002)
Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy
AM Varnava et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Identification of a gene responsible for familial Wolff-Parkinson-White syndrome
MH Gollob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy:: evidence for the central role of energy compromise in disease pathogenesis
E Blair et al.
HUMAN MOLECULAR GENETICS (2001)
The molecular genetic basis for hypertrophic cardiomyopathy
AJ Marian et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
An abnormal Ca2+ response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy
D Fatkin et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease
AM Varnava et al.
HEART (2000)
Hypertrophic cardiomyopathy and sudden death in the young: Pathologic evidence of myocardial ischemia
C Basso et al.
HUMAN PATHOLOGY (2000)
Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death
J Shirani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
分享论文
